Semaglutide is a GLP-1 receptor agonist. It mimics the GLP-1 hormone, which is released naturally after eating, to:
- Reduce appetite and food intake
- Slow the rate at which your stomach empties
- Help regulate blood sugar levels
Wegovy is administered as a once-weekly subcutaneous injection. As with Mounjaro, it is most effective as part of a comprehensive programme that includes lifestyle adjustments.